Clinical Follow-Up of Hydroxyurea-Treated Adults with Sickle Cell Disease

Publisher： Karger

E-ISSN： 1421-9662|125|3|145-152

ISSN： 0001-5792

Source： Acta Haematologica, Vol.125, Iss.3, 2010-12, pp. : 145-152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 11, 2015-11 ,pp. : 1956-1961

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 1545-5009, Iss. 11, 2015-11 ,pp. : 1956-1961

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oscillatory haematopoiesis in adults with sickle cell disease treated with hydroxycarbamide

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 5, 2015-03 ,pp. : 737-746

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is low dose hydroxyurea the solution to the global epidemic of sickle cell disease?

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 6, 2015-06 ,pp. : 929-930

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adults with sickle cell anaemia: specific patient competencies required for day-to-day management of hydroxyurea treatment

By Lelong Anne-Sophie   Perrin Amélie   Mensah Sandrine   de Montalembert Mariane  

Education thérapeutique du Patient - Therapeutic patient education, Vol. 5, Iss. 1, 2013-04 ,pp. : 147-153

Edp Sciences

Access to resources Recommend Favorite